Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

NasdaqCM:SLS
NasdaqCM:SLSBiotechs

A Look At SELLAS Life Sciences Group (SLS) Valuation After New IMPACT AML Clinical Collaboration

SELLAS Life Sciences Group (SLS) is back on investor radars after it agreed with the IMPACT AML network to run a European clinical study of its CDK9 inhibitor, SLS009, in high risk newly diagnosed AML. See our latest analysis for SELLAS Life Sciences Group. The new IMPACT AML agreement comes after a volatile spell where traders focused on financing risk, yet the stock still shows a 74.55% 30 day share price return and a very large 1 year total shareholder return. This suggests momentum has...
XTRA:EOAN
XTRA:EOANIntegrated Utilities

Did E.ON’s €1.6 Billion Bond Sale Just Recast Its Balance Sheet Story (XTRA:EOAN)?

On 12 January 2026, E.ON SE completed a dual fixed‑income offering, issuing €850 million of 3.895% notes due 2038 and €750 million of 3.895% notes due 2034, both priced at 100% of principal with fixed coupons. This sizeable €1.60 billion bond raise, together with recent increases in institutional ownership, highlights investor confidence in E.ON’s funding approach and its regulated, cash flow‑focused business model. We’ll now examine how this €1.60 billion bond issuance may influence E.ON’s...
NYSE:GENI
NYSE:GENIHospitality

Should Wall Street’s Praise of GENI’s Media Strategy Refocus the Genius Sports (GENI) Investment Debate?

In recent days, multiple research firms including Benchmark, Wells Fargo, and Truist Financial have issued upbeat coverage on Genius Sports, emphasizing its operating leverage, media monetization approach, and long-term revenue and cash flow ambitions. This wave of positive attention underscores how Genius Sports’ data partnerships and advertising-focused media strategy have become central to its long-term business case. Building on this new analyst optimism around Genius Sports’ media...
TSE:7730
TSE:7730Medical Equipment

Mani (TSE:7730) Q1 EPS Strength Tests Bullish Margin Recovery Narrative

Mani (TSE:7730) opened Q1 2026 with revenue of ¥7.8b and basic EPS of ¥19.25, alongside net income excluding extra items of ¥1.9b, setting the tone for a results season where profitability is firmly in focus. The company reported revenue of ¥7.7b and EPS of ¥16.23 in Q1 2025 compared with ¥7.8b and EPS of ¥19.25 in Q1 2026, while trailing twelve month EPS stands at ¥50.16 on net income of ¥4.9b. With trailing net margins sitting below last year’s level, this release gives investors fresh...